Amyotrophic lateral sclerosis--a new role for old drugs - PubMed (original) (raw)

. 2005 Mar 31;352(13):1376-8.

doi: 10.1056/NEJMcibr050274.

Affiliations

• PMID: 15800236
• DOI: 10.1056/NEJMcibr050274

Amyotrophic lateral sclerosis--a new role for old drugs

Robert H Brown Jr. N Engl J Med. 2005.

No abstract available

PubMed Disclaimer

Similar articles

• Antibiotics that protect the brain.
  Secko D. Secko D. CMAJ. 2005 Feb 15;172(4):467-8. doi: 10.1503/cmaj.050022. CMAJ. 2005. PMID: 15710934 Free PMC article. No abstract available.
• Medicine. Treating neurodegenerative diseases with antibiotics.
  Miller TM, Cleveland DW. Miller TM, et al. Science. 2005 Jan 21;307(5708):361-2. doi: 10.1126/science.1109027. Science. 2005. PMID: 15661995 No abstract available.
• New ideas for therapy in ALS: critical considerations.
  Beghi E, Bendotti C, Mennini T. Beghi E, et al. Amyotroph Lateral Scler. 2006 Jun;7(2):126-7; discussion 127. doi: 10.1080/14660820510012040. Amyotroph Lateral Scler. 2006. PMID: 16753979 No abstract available.
• [Etiological drug therapy for amyotrophic lateral sclerosis].
  Cintas P. Cintas P. Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S220-4S227. Rev Neurol (Paris). 2006. PMID: 17128115 French.
• Treatment of amyotrophic lateral sclerosis - what is the next step?
  Ludolph AC. Ludolph AC. J Neurol. 2000 Dec;247 Suppl 6:VI/13-8. doi: 10.1007/PL00007783. J Neurol. 2000. PMID: 19714403 Review.

Cited by

• Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.
  Chotibut T, Davis RW, Arnold JC, Frenchek Z, Gurwara S, Bondada V, Geddes JW, Salvatore MF. Chotibut T, et al. Mol Neurobiol. 2014 Jun;49(3):1282-92. doi: 10.1007/s12035-013-8598-0. Epub 2013 Dec 3. Mol Neurobiol. 2014. PMID: 24297323 Free PMC article.
• Amyotrophic lateral sclerosis: update for family physicians.
  Shoesmith CL, Strong MJ. Shoesmith CL, et al. Can Fam Physician. 2006 Dec;52(12):1563-9. Can Fam Physician. 2006. PMID: 17279237 Free PMC article. Review.
• Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.
  Sanacora G, Zarate CA, Krystal JH, Manji HK. Sanacora G, et al. Nat Rev Drug Discov. 2008 May;7(5):426-37. doi: 10.1038/nrd2462. Nat Rev Drug Discov. 2008. PMID: 18425072 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information